All Stories

Q1 biopharma layoff trends, plus expectations for Q2

In this week’s episode of "The Top Line," Fierce Deputy Editor Andrea Park and Fierce Biotech Senior Editor Gabrielle Masson discuss how workforce reductions impacted the biopharma industry in the first quarter.

Apr 11, 2025 - 14:33
 0
Q1 biopharma layoff trends, plus expectations for Q2
In this week’s episode of "The Top Line," Fierce Deputy Editor Andrea Park and Fierce Biotech Senior Editor Gabrielle Masson discuss how workforce reductions impacted the biopharma industry in the first quarter.
Read More

Tags:

Previous Article

PhRMA calls out insurers that own PBMs, pharmacies in new ad

Next Article

STAT+: Pharmalittle: We’re reading about FDA drug reviews, Novartis investing $2...

Related Posts

ALX lays off 30% of staff to pay for more trials of CD47 blocker

ALX lays off 30% of staff to pay for more trials of CD4...

Mar 5, 2025  0

Flagship-backed Sail Biomedicines lays off staff following review of organizational structure

Flagship-backed Sail Biomedicines lays off staff follow...

Apr 1, 2025  0

'One of the lucky few': Bicara's CEO on operating in today's market, while hoping for a different one

'One of the lucky few': Bicara's CEO on operating in to...

Apr 14, 2025  0